Streetbeat News

Stock Prices

ICU

SeaStar Medical Holding's (NYSE:ICU) short interest has increased by 65.93% since the last report, with 2.49 million shares sold short, representing 4.53% of its float. This rise in short interest, which now exceeds the peer group average of 3.94%, could indicate a bearish market sentiment towards ICU. However, an increase in short interest can sometimes be bullish, suggesting potential for profit if the stock price increases.

Portfolio Pulse from Benzinga Insights

March 04, 2024 | 4:45 pm

F

SOXX

TSLA

Tesla shares dropped due to lower February sales in China, while the semiconductor sector continued to rise. Ford reported an increase in its February sales.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 4:39 pm

FUBO

FuboTV Inc (NYSE:FUBO) shares rose after reporting Q4 results, showing effective cost-cutting and reiterating its 2025 guidance for positive free cash flows. Seaport Research Partners upgraded FuboTV to a Buy and raised the price target to $2.50, citing higher-than-expected subscription revenue and potential benefits from an antitrust lawsuit. Shares were up 0.5% to $1.91.

Portfolio Pulse from Priya Nigam

March 04, 2024 | 4:38 pm

GSL

Global Ship Lease Inc (NYSE:GSL) reported Q4 FY23 results with an 8.4% Y/Y increase in operating revenue to $178.9 million, surpassing consensus estimates. However, operating income fell to $78.9 million from $85.1 million Y/Y. Adjusted EBITDA and normalized EPS both saw significant increases. The company declared a dividend of $0.375 per share, payable in March 2024. Trade disruptions in the Red Sea and water shortages in the Panama Canal have tightened containership supply and demand, impacting charter rates and asset values. Despite positive financial results, GSL shares dropped 6.6% to $19.24.

Portfolio Pulse from Lekha Gupta

March 04, 2024 | 4:38 pm

OILFF

Nextleaf Solutions Ltd. (OTCQB:OILFF), a cannabis processor, reported a 170% YoY increase in net revenue to $2.4 million for Q1 2024, marking its highest gross sales period. The company, which launched its house brands in Alberta, plans to introduce nine new products nationwide. Despite higher expenses, Nextleaf maintained a debt-free position and saw its shares rise 1.6904% to $0.1143.

Portfolio Pulse from Jelena Martinovic

March 04, 2024 | 4:35 pm

CEG

UBS analyst Ross Fowler maintains a Buy rating on Constellation Energy (NASDAQ:CEG) and raises the price target from $151 to $201.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 4:32 pm

IP

SON

TROX

Wall Street's most accurate analysts recommend three high-dividend yielding materials stocks: International Paper Company (IP), Tronox Holdings plc (TROX), and Sonoco Products Company (SON). IP reported lower than expected Q4 sales, TROX posted upbeat quarterly sales, and SON reported downbeat Q4 earnings. Analysts have adjusted their price targets and ratings for these stocks, reflecting their performance and market outlook.

Portfolio Pulse from Avi Kapoor

March 04, 2024 | 4:31 pm

IGT

International Game Technology (IGT) shares dropped following a downgrade by Stifel from Buy to Hold, with a price target reduction from $31 to $30.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 4:28 pm

AKRO

Akero Therapeutics Inc (NASDAQ:AKRO) shares surged after announcing positive week 96 results from its Phase 2b HARMONY study of efruxifermin (EFX) for MASH, fibrosis stage 2 or 3. The study showed significant improvement in fibrosis without worsening of MASH, with response rates and placebo-adjusted effect sizes increasing notably from week 24 to week 96. EFX was well-tolerated with no deaths and balanced serious adverse events across dose groups. Despite positive results in the HARMONY study, EFX did not show statistical significance in the SYMMETRY Phase 2b trial for improving liver scarring in compensated cirrhosis due to MASH. AKRO shares rose 13.20% to $31.53.

Portfolio Pulse from Vandana Singh

March 04, 2024 | 4:28 pm

NFE

New Fortress Energy's stock trades lower following a $500 million proposed offering of senior secured notes and a downgrade by Deutsche Bank from Buy to Hold, with a reduced price target from $40 to $35.

Portfolio Pulse from Benzinga Newsdesk

March 04, 2024 | 4:25 pm